Geode Capital Management, LLC Adverum Biotechnologies, Inc. Transaction History

Geode Capital Management, LLC

$1.21 Trillion
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$1.5 - $2.33 $34,260 - $53,217	-22,840 Reduced 2.57%	864,206 $1.3 Million
Q2 2023 Aug 11, 2023	BUY	$0.68 - $1.59 $67,419 - $157,642	99,146 Added 12.58%	887,046 $1.41 Million
Q1 2023 May 15, 2023	BUY	$0.62 - $0.85 $9,763 - $13,385	15,748 Added 2.04%	787,900 $567,000
Q4 2022 Feb 13, 2023	BUY	$0.54 - $10.3 $8,944 - $170,598	16,563 Added 2.19%	772,152 $447,000
Q3 2022 Nov 14, 2022	BUY	$0.96 - $9.68 $2,483 - $25,042	2,587 Added 0.34%	755,589 $717,000
Q2 2022 Aug 12, 2022	SELL	$0.81 - $1.34 $544,838 - $901,337	-672,640 Reduced 47.18%	753,002 $903,000
Q1 2022 May 13, 2022	SELL	$1.23 - $1.95 $186,817 - $296,173	-151,884 Reduced 9.63%	1,425,642 $1.87 Million
Q4 2021 Feb 11, 2022	BUY	$1.74 - $2.4 $75,858 - $104,632	43,597 Added 2.84%	1,577,526 $2.78 Million
Q3 2021 Nov 12, 2021	SELL	$2.08 - $3.6 $138,858 - $240,332	-66,759 Reduced 4.17%	1,533,929 $3.33 Million
Q2 2021 Aug 13, 2021	BUY	$3.36 - $10.56 $325,973 - $1.02 Million	97,016 Added 6.45%	1,600,688 $5.6 Million
Q1 2021 May 12, 2021	BUY	$9.26 - $14.36 $1.29 Million - $2 Million	139,259 Added 10.21%	1,503,672 $14.8 Million
Q4 2020 Feb 12, 2021	BUY	$9.84 - $14.26 $663,973 - $962,222	67,477 Added 5.2%	1,364,413 $14.8 Million
Q3 2020 Nov 13, 2020	BUY	$10.3 - $21.64 $2.57 Million - $5.41 Million	249,853 Added 23.86%	1,296,936 $13.4 Million
Q2 2020 Aug 13, 2020	BUY	$8.53 - $25.64 $1.17 Million - $3.53 Million	137,614 Added 15.13%	1,047,083 $21.9 Million
Q1 2020 May 14, 2020	BUY	$7.98 - $16.32 $1.11 Million - $2.28 Million	139,680 Added 18.15%	909,469 $8.89 Million
Q4 2019 Feb 13, 2020	SELL	$5.12 - $12.22 $220,943 - $527,329	-43,153 Reduced 5.31%	769,789 $8.87 Million
Q3 2019 Nov 12, 2019	BUY	$5.24 - $15.89 $18,140 - $55,011	3,462 Added 0.43%	812,942 $4.43 Million
Q2 2019 Aug 14, 2019	BUY	$5.1 - $11.89 $85,980 - $200,453	16,859 Added 2.13%	809,480 $9.62 Million
Q1 2019 May 14, 2019	BUY	$3.03 - $6.02 $284,883 - $566,006	94,021 Added 13.46%	792,621 $4.15 Million
Q4 2018 Feb 13, 2019	BUY	$2.87 - $5.92 $330,540 - $681,812	115,171 Added 19.74%	698,600 $2.2 Million
Q3 2018 Nov 13, 2018	BUY	$4.5 - $7.6 $557,253 - $941,138	123,834 Added 26.94%	583,429 $3.53 Million
Q2 2018 Aug 14, 2018	BUY	$5.3 - $6.9 $944,677 - $1.23 Million	178,241 Added 63.35%	459,595 $2.44 Million
Q1 2018 May 15, 2018	BUY	$3.65 - $7.95 $679,272 - $1.48 Million	186,102 Added 195.38%	281,354 $1.63 Million
Q2 2017 Aug 14, 2017	BUY	N/A	95,252	95,252 $238,000

Others Institutions Holding ADVM

# of Institutions

Shares Held

524K

Call Options Held

Put Options Held

Versant Venture Management, LLC San Francisco, CA

507K
Shares

$2.4 Million
9.32% of portfolio
Pinz Capital Management, LP New York, NY

15.7K
Shares

$74,418
0.03% of portfolio
American Portfolios Advisors Holbrook, NY

1.15K
Shares

$5,451
0.0% of portfolio

View Full List

About Adverum Biotechnologies, Inc.

Ticker ADVM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,333,600
Market Cap $471M
Description
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...

More about ADVM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account